Deborah Knobelman serves as Executive at Senti Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Deborah Knobelman has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 3, 2024 involved receiving (via award) 164,260 shares valued at $0.
Deborah Knobelman currently holds 164,260 shares of Senti Biosciences, Inc. (SNTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Deborah Knobelman has been a net neutral trader of SNTI stock. They have purchased $0 and sold $0 worth of shares.
Deborah Knobelman's most recent insider trade was on Jun 3, 2024, when they sold 164,260 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 3, 2022 | SNTI | $0 | Award | 30,000 | $N/A | Discretionary |